Webinar: A Deep Dive: FDA Draft Guidance on Statistical Approaches to Establishing Bioequivalence [BE/BA News]

posted by Achievwin – US, 2023-02-07 08:13 (828 d 18:44 ago) – Posting: # 23441
Views: 7,760

Wishful thinking: I hope they give clear direction (kill once for all) - the annoying center/group effect portion for BE studies conducted in one country and in homogenous population.

As many times and on many platforms they mentioned it is irrelevant in BE/ANDA contecxt some academic curiosity folks keep brining this topic and keep the topic alive.

❝ FDA is organizing a webinar: A Deep Dive: FDA Draft Guidance on Statistical Approaches to Establishing Bioequivalence


Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,671 registered users;
57 visitors (0 registered, 57 guests [including 38 identified bots]).
Forum time: 03:57 CEST (Europe/Vienna)

A statistical analysis, properly conducted, is a delicate dissection of
uncertainties, a surgery of suppositions.    Micheal J. Moroney

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5